Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Inhibitor of selectin-dependent cell adhesion (BMS-184000) evaluated in models of inflammation

Nov. 19, 1998

ACR attendants learn more about the efficacy and safety of Enbrel in patients with RA, JRA

Nov. 19, 1998

p38 kinase inhibitor RWJ-68354: a promising clinical candidate for inflammatory conditions

Nov. 19, 1998

Novel antibody with potential in treating RA investigated by Santen

Nov. 18, 1998

MMP inhibitor BMS-453 improves disease symptoms in mice with experimental arthritis

Nov. 18, 1998

SB pursues CCR5 antagonists for the treatment of inflammation

Nov. 18, 1998

New osteoarthritis treatment candidate blocks cartilage degradation

Nov. 18, 1998

MK-966 improves physical ability and quality of life in patients with OA, RA

Nov. 18, 1998

Amgen evaluates novel TNF-targeted immunotherapy in patients with active RA

Nov. 17, 1998

Stromelysin inhibitor Bay-12-9566 enters clinical testing for a second indication

Nov. 17, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...